Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03639194 |
|---|---|
| Brief Title: | A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer |
| First Submitted : | August 17, 2018 |
| First Submitted that Met QC Criteria : | August 17, 2018 |
| First Posted : | August 21, 2018 |
| Last Update Submitted that Met QC Criteria : | February 8, 2024 |
| Last Update Posted : | February 9, 2024 |